Harding, Margaret; Manohari Abeysinghe, p
This Perspective will focus on recent developments in the field of antitumour metallocenes structurally related to titanocene dichloride. Despite extensive testing of titanocene dichloride which culminated in phase I and II clinical trials, further trials have been abandoned. While DNA has been implicated as the major target related to anticancer activity, identification of the active species and mechanism of action has been poorly understood and hence the design of second generation titanocene...[Show more]
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.